InfuSystem Holdings Files 8-K for Regulation FD Disclosure
Ticker: INFU · Form: 8-K · Filed: Dec 4, 2024 · CIK: 1337013
| Field | Detail |
|---|---|
| Company | Infusystem Holdings, INC (INFU) |
| Form Type | 8-K |
| Filed Date | Dec 4, 2024 |
| Risk Level | low |
| Pages | 2 |
| Reading Time | 2 min |
| Sentiment | neutral |
Sentiment: neutral
Topics: regulation-fd, disclosure
TL;DR
InfuSystem Holdings filed an 8-K for a Reg FD disclosure. No major news, just compliance.
AI Summary
InfuSystem Holdings, Inc. filed an 8-K on December 4, 2024, to report a Regulation FD Disclosure. The filing does not contain specific financial figures or material events beyond the disclosure itself.
Why It Matters
This filing indicates InfuSystem Holdings is making a public disclosure under Regulation FD, ensuring all investors receive the same material information simultaneously.
Risk Assessment
Risk Level: low — The filing is a standard regulatory disclosure and does not appear to contain any new material adverse information.
Key Players & Entities
- InfuSystem Holdings, Inc. (company) — Registrant
- December 4, 2024 (date) — Date of Report
- Regulation FD (regulation) — Type of Disclosure
FAQ
What is the primary purpose of this 8-K filing?
The primary purpose of this 8-K filing is to report a Regulation FD Disclosure by InfuSystem Holdings, Inc.
What is the date of this filing?
The filing was made on December 4, 2024.
What is the company's principal executive office address?
The company's principal executive office is located at 3851 West Hamlin Road, Rochester Hills, Michigan 48309.
What is the Commission File Number for InfuSystem Holdings, Inc.?
The Commission File Number for InfuSystem Holdings, Inc. is 001-35020.
What is the SIC code for InfuSystem Holdings, Inc.?
The Standard Industrial Classification (SIC) code for InfuSystem Holdings, Inc. is 3841, which corresponds to SURGICAL & MEDICAL INSTRUMENTS & APPARATUS.
Filing Stats: 509 words · 2 min read · ~2 pages · Grade level 11.9 · Accepted 2024-12-04 16:30:07
Filing Documents
- infu-20241204.htm (8-K) — 28KB
- exhibit9913q24investorpr.htm (EX-99.1) — 28KB
- exhibit9913q24investorpr001.jpg (GRAPHIC) — 93KB
- exhibit9913q24investorpr002.jpg (GRAPHIC) — 200KB
- exhibit9913q24investorpr003.jpg (GRAPHIC) — 107KB
- exhibit9913q24investorpr004.jpg (GRAPHIC) — 111KB
- exhibit9913q24investorpr005.jpg (GRAPHIC) — 126KB
- exhibit9913q24investorpr006.jpg (GRAPHIC) — 94KB
- exhibit9913q24investorpr007.jpg (GRAPHIC) — 115KB
- exhibit9913q24investorpr008.jpg (GRAPHIC) — 94KB
- exhibit9913q24investorpr009.jpg (GRAPHIC) — 101KB
- exhibit9913q24investorpr010.jpg (GRAPHIC) — 99KB
- exhibit9913q24investorpr011.jpg (GRAPHIC) — 103KB
- exhibit9913q24investorpr012.jpg (GRAPHIC) — 127KB
- exhibit9913q24investorpr013.jpg (GRAPHIC) — 89KB
- exhibit9913q24investorpr014.jpg (GRAPHIC) — 100KB
- exhibit9913q24investorpr015.jpg (GRAPHIC) — 92KB
- exhibit9913q24investorpr016.jpg (GRAPHIC) — 88KB
- exhibit9913q24investorpr017.jpg (GRAPHIC) — 88KB
- exhibit9913q24investorpr018.jpg (GRAPHIC) — 90KB
- exhibit9913q24investorpr019.jpg (GRAPHIC) — 81KB
- exhibit9913q24investorpr020.jpg (GRAPHIC) — 55KB
- exhibit9913q24investorpr021.jpg (GRAPHIC) — 104KB
- exhibit9913q24investorpr022.jpg (GRAPHIC) — 127KB
- 0001628280-24-049931.txt ( ) — 3334KB
- infu-20241204.xsd (EX-101.SCH) — 2KB
- infu-20241204_lab.xml (EX-101.LAB) — 21KB
- infu-20241204_pre.xml (EX-101.PRE) — 12KB
- infu-20241204_htm.xml (XML) — 3KB
01 - Regulation FD Disclosure
Item 7.01 - Regulation FD Disclosure InfuSystem Holdings, Inc. (the "Company") hereby furnishes the information set forth in the Investor Presentation dated December 4, 2024, which is attached hereto as Exhibit 99.1. The information furnished in this Item 7.01 — "Regulation FD Disclosure" of this Current Report on Form 8-K and the Investor Presentation attached hereto as Exhibit 99.1 shall not be deemed "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934, as amended, or otherwise subject to the liabilities of such section, and shall not be deemed to be incorporated by reference into the filings of the Company under the Securities Act of 1933, as amended, or the Securities Exchange Act of 1934, as amended.
01 - Financial Statements and Exhibits
Item 9.01 - Financial Statements and Exhibits (d) Exhibits Exhibit No. Description 99.1 InfuSystem Holdings, Inc. Investor Presentation dated December 4 , 2024 104 Cover Page Interactive Data File (embedded within the Inline XBRL document) SIGNATURE Pursuant to the requirements of the Securities Exchange Act of 1934 the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. INFUSYSTEM HOLDINGS, INC. By: /s/ Barry Steele Barry Steele Chief Financial Officer Dated: December 4, 2024